arginine has been researched along with Thromboembolism in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.56) | 18.7374 |
1990's | 10 (27.78) | 18.2507 |
2000's | 14 (38.89) | 29.6817 |
2010's | 9 (25.00) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Alwis, I; Hofma, BR; Jackson, SP; Maclean, JAA; Samson, AL; Schoenwaelder, SM; Sturgeon, SA; Tomkins, AJ | 1 |
Banik, N; Beyer-Westendorf, J; Brachmann, J; Dohmen, PM; Eberle, S; Hankowitz, J; Klamroth, R; Kropff, S; Lindhoff-Last, E; Madlener, K; Müller, MM; Pötzsch, B; Schellong, S; Schindewolf, M; Steindl, J | 1 |
Al-Eidan, FAS; Alrawkan, S; Alshammary, H; Crowther, MA | 1 |
Pötzsch, B | 1 |
Hirade, R; Mihara, T; Nikai, T; Ota, J; Saito, Y; Sakakibara, S | 1 |
Ansell, J; Bakhru, S; Costin, J; Laulicht, B; Steiner, S | 1 |
Baumgarten, G; Boehm, O; Graeff, I; Hoeft, A; Kim, SC; Schewe, JC; Tran, N; Wittmann, M | 1 |
Kaatz, S; Milling, TJ | 1 |
Boggio, LN; Oza, VM | 1 |
Haeberle, L; Nohe, B; Ploppa, A; Schmid, E | 1 |
Hetzer, R; Koster, A; Krabatsch, T; Maj, G; Pappalardo, F; Potapov, E; Scandroglio, AM; Stepanenko, A; Zangrillo, A | 1 |
Aizawa, Y; Fuse, I; Hanzawa, K; Hayashi, J; Higuchi, K; Hori, T; Matsubara, T; Mezaki, T; Moro, H; Nasuno, A; Tanaka, K; Tanaka, T; Tsuchida, K | 1 |
Damiano, RJ; Deshpande, SP; Lawton, JS; Zanaboni, PB | 1 |
Bhatt, DL; Gurm, HS | 1 |
Büller, HR; Di Nisio, M; Middeldorp, S | 1 |
Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D | 1 |
Boshkov, LK; Kirby, A; Shen, I; Ungerleider, RM | 1 |
Bonderman, D; Hitsch, R; Jakowitsch, J; Klepetko, W; Kneussl, MP; Lang, IM; Mittermayer, F; Panzenboeck, A; Sadushi, R; Skoro-Sajer, N; Wolzt, M | 1 |
Fujita, S; Itonaga, T; Masumoto, H; Nakai, M; Nomura, R; Shimamoto, M; Yamazaki, F | 1 |
Berends, F; Büller, H; Koopman, R; Mertens, K; Roelse, J; ten Cate, JW; van Mourik, JA; Voorberg, J | 1 |
Ameriso, SF; Fernandez, JA; Fisher, M; Griffin, JH; Gruber, A; Paganini-Hill, A; Xie, D | 1 |
Alving, BM; Carrington, LR; Gillespie, DL; Griffin, JH | 1 |
Dübbers, A; Nowak-Göttl, U; Oleszuk-Raschke, K; Sträter, R; Vielhaber, H | 1 |
Johnsen, AH; Lind, B; Thorsen, S | 1 |
Busto, R; Dietrich, WD; Green, EJ; Prado, R; Stagliano, NE | 1 |
Dewanjee, MK | 1 |
Broeders, MA; oude Egbrink, MG; Reneman, RS; Slaaf, DW; Tangelder, GJ | 2 |
Barrowcliffe, TW; Goodnight, SH; Green, D; Laposata, M; Sosolik, RC; Van Cott, EM | 1 |
Hoson, M; Kawada, T; Kitagawa, H; Okada, Y; Shiomura, J | 1 |
Kondo, LM; Wiggins, BS; Wittkowsky, AK | 1 |
Fleischer, K; Gulba, DC; Lankes, W | 1 |
Rezaei Kalantari, H | 1 |
Cooper, DN; Grundy, CB; Kakkar, VV; Kobosko, J; Krawczak, M; Schulman, S | 1 |
Beresford, CH; Carrell, RW; Owen, MC | 1 |
Kirsteins, L; Lawrence, AM | 1 |
11 review(s) available for arginine and Thromboembolism
Article | Year |
---|---|
[Anticoagulation].
Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K | 2013 |
Reversal agents in development for the new oral anticoagulants.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Humans; Piperazines; Recombinant Proteins; Thromboembolism | 2014 |
Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
Topics: Animals; Antidotes; Arginine; Atrial Fibrillation; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Piperazines; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thromboembolism | 2016 |
Argatroban use in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Clinical Trials as Topic; Heparin; Humans; Liver; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thromboembolism | 2008 |
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.
Topics: Adolescent; Anticoagulants; Arginine; Autoantibodies; Cardiopulmonary Bypass; Child; Child, Preschool; Clinical Trials as Topic; Fatal Outcome; Female; Heart Defects, Congenital; Heparin; Hirudins; Hospitals, University; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Multicenter Studies as Topic; Pipecolic Acids; Platelet Factor 4; Postoperative Complications; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2006 |
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pathology, Clinical; Pipecolic Acids; Sulfonamides; Thromboembolism | 1998 |
Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation.
Topics: Animals; Anticoagulants; Arginine; Child; Extracorporeal Circulation; Heart Bypass, Left; Heparin; Humans; Pediatrics; Pipecolic Acids; Sulfonamides; Thromboembolism | 2000 |
Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thromboembolism | 2001 |
[Direct thrombin antagonists].
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithrombins; Arginine; Azetidines; Benzylamines; Fibrinolytic Agents; Glycine; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Rabbits; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Time Factors | 2001 |
[How I treat ... sickle cell anemia: current therapies].
Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antisickling Agents; Arginine; Aspirin; Blood Transfusion; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Hydroxyurea; Nitric Oxide; Thromboembolism; Transplantation, Homologous | 2001 |
25 other study(ies) available for arginine and Thromboembolism
Article | Year |
---|---|
Development of a carotid artery thrombolysis stroke model in mice.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Carotid Artery, Common; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Pipecolic Acids; Stroke; Sulfonamides; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Fondaparinux; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Hospital Mortality; Hospitalization; Humans; Male; Necrosis; Off-Label Use; Partial Thromboplastin Time; Patient Safety; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2017 |
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.
Topics: Aged; Arginine; Fondaparinux; Heparin; Humans; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism | 2018 |
[Recipient of living kidney transplantation during which heparin-induced thrombocytopenia (HIT) was suspected: a case report].
Topics: Aged; Anesthesia, General; Anticoagulants; Antithrombins; Arginine; Diabetic Nephropathies; Drug Substitution; Female; Heparin; Humans; Kidney Transplantation; Living Donors; Perioperative Care; Pipecolic Acids; Postoperative Complications; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2014 |
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
Topics: Adult; Aged; Anticoagulants; Arginine; Critical Illness; Dose-Response Relationship, Drug; Drug Costs; Female; Germany; Health Care Costs; Hemorrhage; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism | 2015 |
Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Echocardiography, Transesophageal; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia; Thromboembolism; Ventricular Dysfunction, Left | 2013 |
Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
Topics: Adult; Aged; Anticoagulants; Arginine; Feasibility Studies; Female; Heart Transplantation; Heart-Assist Devices; Heparin; Hospital Mortality; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2012 |
Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Acute Disease; Anticoagulants; Arginine; Catheterization; Catheterization, Central Venous; Coated Materials, Biocompatible; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Radionuclide Imaging; Sulfonamides; Syndrome; Thrombocytopenia; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography | 2003 |
Spontaneous atrioventricular groove disruption during off-pump coronary artery bypass grafting.
Topics: Aged; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass, Off-Pump; Coronary Stenosis; Emergencies; Fatal Outcome; Female; Heart Injuries; Heparin; Humans; Hypertension, Pulmonary; Internal Mammary-Coronary Artery Anastomosis; Intraoperative Complications; Mitral Valve; Myocardial Infarction; Pipecolic Acids; Postoperative Complications; Rupture, Spontaneous; Sulfonamides; Suture Techniques; Thrombocytopenia; Thromboembolism | 2005 |
Direct thrombin inhibitors.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Blood Coagulation; Dabigatran; Heart Diseases; Heparin; Humans; Pipecolic Acids; Prodrugs; Pyridines; Sulfonamides; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin | 2005 |
Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
Topics: Aged; Arginine; Chronic Disease; Endothelial Cells; Enzyme Inhibitors; Female; Humans; Hypertension, Pulmonary; Kaplan-Meier Estimate; Male; Middle Aged; Nitric Oxide Synthase; Osmolar Concentration; Prognosis; Pulmonary Artery; Severity of Illness Index; Thromboembolism | 2007 |
A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Leg; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombectomy; Thrombocytopenia; Thromboembolism | 2007 |
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
Topics: Adult; Aged; Arginine; Base Composition; Base Sequence; DNA Primers; Factor V; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Point Mutation; Protein C; Recurrence; Thromboembolism | 1994 |
Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.
Topics: Arginine; Blood Coagulation; Brain Ischemia; Carrier Proteins; Cerebrovascular Disorders; Factor V; Female; Glutamine; Hispanic or Latino; Humans; Los Angeles; Male; Middle Aged; Partial Thromboplastin Time; Point Mutation; Prevalence; Risk Factors; Thromboembolism | 1996 |
Resistance to activated protein C: a common inherited cause of venous thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Arginine; Contraceptives, Oral; DNA; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Mutation; Obesity; Pregnancy; Protein C; Protein C Deficiency; Protein S Deficiency; Recurrence; Risk Factors; Thromboembolism; Thrombophlebitis | 1996 |
Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.
Topics: Adolescent; Arginine; Arterial Occlusive Diseases; Brain Ischemia; Child; Child, Preschool; Enzyme Activation; Factor V; Female; Glutamine; Humans; Infant; Infant, Newborn; Male; Point Mutation; Prospective Studies; Protein C; Risk Factors; Thromboembolism | 1996 |
Naturally occurring Arg(-1) to His mutation in human protein C leads to aberrant propeptide processing and secretion of dysfunctional protein C.
Topics: Amino Acid Sequence; Antimicrobial Cationic Peptides; Arginine; Disease Susceptibility; Histidine; Humans; Male; Middle Aged; Peptides; Point Mutation; Protein C; Protein C Deficiency; Protein Precursors; Protein Processing, Post-Translational; Thromboembolism | 1997 |
The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat.
Topics: Animals; Arginine; Behavior, Animal; Blood Pressure; Cerebrovascular Disorders; Citrulline; Cognition Disorders; Enzyme Inhibitors; Intracranial Embolism and Thrombosis; Male; Motor Cortex; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Somatosensory Cortex; Thromboembolism | 1997 |
Stroke from heparin-coated circuits and reduced systemic anticoagulation.
Topics: Animals; Anticoagulants; Arginine; Cardiopulmonary Bypass; Cerebrovascular Disorders; Heparin; Humans; Male; Swine; Thromboembolism | 1997 |
Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles.
Topics: Animals; Arginine; Arterioles; Female; Male; Microscopy, Video; Nitric Oxide; Nitroarginine; Nitroprusside; Rabbits; Rupture; Thromboembolism; Venules | 1998 |
Hypercholesterolemia enhances thromboembolism in arterioles but not venules: complete reversal by L-arginine.
Topics: Animals; Arginine; Arterioles; Diet, Atherogenic; Hypercholesterolemia; Male; Nitric Oxide; Rabbits; Thromboembolism; Time Factors; Venules | 2002 |
Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene.
Topics: Amino Acid Sequence; Arginine; Base Sequence; Exons; Female; Genetic Carrier Screening; Humans; Male; Molecular Sequence Data; Mutation; Oligodeoxyribonucleotides; Pedigree; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein C; Protein C Deficiency; Thromboembolism | 1992 |
Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
Topics: Adult; Amino Acid Sequence; Antithrombin III; Arginine; Binding Sites; Heparin; Histidine; Humans; Male; Thrombin; Thromboembolism | 1988 |
Progestins in the medical management of active acromegaly.
Topics: Acromegaly; Arginine; Carcinoma; Depression, Chemical; Endometrial Hyperplasia; Estrogens; Female; Feminization; Glucose Tolerance Test; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Immunoassay; Medroxyprogesterone; Metrorrhagia; Thromboembolism | 1970 |